Myositis clinical trials

The registry lists 215 studies for Myositis across more than 10 countries. 100 are recruiting or about to start. 61 of them are mainly about Myositis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 4 narrower conditions too, such as Dermatomyositis: 420 studies, 159 open.

Get an email when these change. Save the Myositis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting: 71
Completed: 60
Not yet recruiting: 23
Status unknown: 20
Active, not recruiting: 14
Terminated: 10

Phase

Phase 2: 49
Phase 1: 45
Early Phase 1: 20
Phase 3: 18
Phase 4: 9

Where

United States: 78
China: 54
France: 40
United Kingdom: 22
Germany: 21
Spain: 18

Who runs them

Assistance Publique - Hôpitaux de Paris (9) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (8) · Peking University People's Hospital (7) · China Immunotech (Beijing) Biotechnology Co., Ltd. (6) · National Institute of Environmental Health Sciences (NIEHS) (6) · Tongji Hospital (5) · Novartis Pharmaceuticals (4) · University of Sao Paulo (4)

What is being tested here

Drugs under test in Myositis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
YTS109	6	0	6
Anti-CD19 CAR T Cells Preparation	3	0	3
Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F	3	0	3
Cyclophosphamide	3	0	3
Fludarabine	2	0	2
Pirfenidone	1	0	2
RD06-04	1	0	2
Efgartigimod alfa	1	1	1
Hyaluronidase (human recombinant)	1	1	1
Autologous Anti-CD19/CD20 CAR-T Cells KITE-363	1	0	1

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open

Coming up

8phase 3 studies under way

32studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) · Phase 3 · Zhongming Qiu
Nov 2026A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis · argenx
Nov 2026Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases · Polina Stepensky
Nov 2026Safety Study of CC312 in Autoimmune Disease Patients · CytoCares Inc
Nov 2026Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases · China Immunotech (Beijing) Biotechnology Co., Ltd.
Nov 2026An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases · China Immunotech (Beijing) Biotechnology Co., Ltd.
Dec 2026A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease · Adicet Therapeutics
Dec 2026Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases · UMC Utrecht
Dec 2026Inspiratory Muscle Training in Patients With Inflammatory Myopathy · Józef Piłsudski University of Physical Education
Dec 2026Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients · Hospital Universitario Araba

Who these studies take

Of the 71 Myositis studies recruiting now, 27 (38%) set no upper age limit and 36 (51%) stop at 75 or younger. 7 (10%) take children under 18. 0 (0%) are for women only and 1 (1%) for men only; 9 (13%) take healthy volunteers.

Recruiting studies that take each age, of 71
Age	Women	Men
10	5 (7%)	5 (7%)
18	67 (94%)	67 (94%)
30	69 (97%)	69 (97%)
40	69 (97%)	69 (97%)
50	70 (99%)	71 (100%)
65	67 (94%)	68 (96%)
75	43 (61%)	44 (62%)
85	31 (44%)	32 (45%)

Across all 215 studies, recruiting or not: 33% stop at 75 or younger and 13% at 65; 15% take children; <1% are for women only and <1% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Myositis studies take

Of 19 interventional studies with no phase under Myositis, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	23 mo12–51 · 19 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 215. Browse all 215 → or search them.